TARGET XL M0036115150Recalls & reported problems
Stryker Corporation · Helical Detachable Coil · Class 2 · Implant
All models of TARGET XL (34)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 07613327004571), received between Nov 21, 2016 and Jul 7, 2021 — classified as 4 malfunctions.
The most frequently reported specific device problem is “Premature Activation” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Premature Activation3
- Premature Separation1
Patient problems
- No Consequences Or Impact To Patient3
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionJul 7, 2021Premature Separation; Premature Separation
IT WAS REPORTED THAT DURING THE PROCEDURE WHEN THE PHYSICIAN ADVANCED COIL (SUBJECT DEVICE) INSIDE THE PROXIMAL OF THE MICROCATHETER RESISTANCE WAS ENCOUNTERED. THEN THE SUBJECT COIL PREMATURELY DETACHED INSIDE THE MICROCATHETER. THE DETACHED SUBJECT COIL WAS REMOVED ALONG WITH THE MICROCATHETER. THE PROCEDURE WAS COMPLETED SUCCESSFULLY. NO CLINICAL CONSEQUENCES WERE REPORTED TO THE PATIENT DUE TO THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12131925 ↗MalfunctionDec 18, 2017Premature Activation; Premature Activation
DURING THE COIL EMBOLIZATION PROCEDURE, IT WAS REPORTED THAT THE RESISTANCE WAS FELT WHEN ADVANCING THE SUBJECT COIL IN THE MICROCATHETER. SO THE PHYSICIAN REMOVED THE COIL AND THE COIL WAS PREMATURELY DETACHED IN THE MICROCATHETER. THEN THE DETACHED COIL WAS REMOVED TOGETHER WITH THE MICROCATHETER. THE SAME EVENT ALSO HAPPENED TO ANOTHER COIL USED IN THE PROCEDURE. NO CLINICAL CONSEQUENCES REPORTED TO THE PATIENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7127829 ↗MalfunctionDec 12, 2016Premature Activation; Premature Activation
ANALYSIS OF THE RETURNED DEVICE REVEALED THAT THE MAIN COIL HAD DETACHED/SEPARATED FROM THE DELIVERY WIRE. THERE WERE NO REPORTED CLINICAL CONSEQUENCES TO THE PATIENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6168675 ↗MalfunctionNov 21, 2016Premature Activation; Premature Activation
IT WAS REPORTED THAT DURING THE REPOSITIONING OF THE COILS IN THE ANEURYSM, EACH DETACH MECHANICALLY AT THE DETACHMENT ZONE. EACH OF THE COILS WAS RESPECTIVELY REMOVED TOGETHER WITH THE MICROCATHETER EVERY TIME WITHOUT CLINICAL CONSEQUENCES TO THE PATIENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6117091 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page